Outcome in patients with idiopathic retroperitoneal fibrosis treated with corticosteroid or tamoxifen monotherapy

BACKGROUND: Although corticosteroids (CS) are used primarily in idiopathic retroperitoneal fibrosis (iRPF), tamoxifen (TMX) may be a suitable alternative. We compared outcome with CS or TMX monotherapy for first presentation in a large group of patients with iRPF disease. METHODS: Of all patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Bilt, Floor E., Hendriksz, Tadek R., van der Meijden, Wilbert A.G., Brilman, Lisette G., van Bommel, Eric F.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Rare Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792623/
https://www.ncbi.nlm.nih.gov/pubmed/26985367
http://dx.doi.org/10.1093/ckj/sfv148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792623/
https://www.ncbi.nlm.nih.gov/pubmed/26985367
http://dx.doi.org/10.1093/ckj/sfv148

Ejemplares similares